RE:RE:RE:RE:RE:RE:New article in La Presse this morning Sorry SPCEO1, but Philippe's comment jfm shared from the French paper makes zero sense within the context of the assumptions you're making. Maybe there's a language barrier? I have to assume Philippe would have chosen very different words if they had been in blackout and not reference buying shares "this week" and then go on to specifically identify the end of the quarter and the release of financial results as a current blackout period. That is a normal blackout period for most companies, and it sounds like an excuse. And yet, it still doesn't explain why those expired options haven't been dealth with. I would very much like to know the status of those options. On the flip side, maybe this is Philippe's horrible way of communicating that they have been in blackout for 9 full months due to something we don't know about and that very thing is so material that it's prevented them from doing anything. I just can't believe that to be the case. These guys still do not have my trust, but I thought Philippe's comments were fairly clear. If he's trying to hint at something here, it didn't come through for me on his specific statement.
'Theratechnologies executives did not buy shares of the company this week because they could not do so due to regulations. “We are often in blackout [period of prohibition to conclude transactions], and this is the case at the moment between the end of the quarter and the release of results at the end of September,” says Philippe Dubuc.'
Do you beleive they've been in blackout this entire year? If so, what realistically would be cause for such extreme caution on any insider transactions?